GlassScriptPhysician profile
Glenna R Andersen
NPI 1447241989
$496.76
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $130 · 2022: $19.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $152.31 | 2019-2022 | |
| Avion Pharmaceuticals | $54.31 | 2020 | |
| Amag Pharmaceuticals, INC. | $38.27 | 2019 | |
| Pfizer INC. | $37.47 | 2019 | |
| Therapeuticsmd, INC. | $35.32 | 2019 | |
| Roche Diagnostics Corporation | $35.12 | 2019 | |
| Allergan, INC. | $25.41 | 2019 | |
| Daiichi Sankyo INC. | $23.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.06 | 2020 | |
| Millicent US INC | $19.50 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.60 | 2019 | |
| Merck Sharp & Dohme LLC | $15.02 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.46 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenna Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.